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angioscopy has any impact on primary graft patency, can
minimize the risk of failing graft caused by postoperative
arteriovenous fistulas or stenosis, and thereby reduce the
need for reintervention. 
PATIENTS AND METHODS
Patients requiring femorodistal arterial reconstruction
between January 1996 and December 1998 at the
Division of Vascular Surgery, Lund University Hospital,
were, if a suitable vein was present, assigned to undergo
saphenous vein bypass in situ. In all cases the indication for
surgery was critical leg ischemia, according to the classifi-
cation of Fontaine III and IV,8 and all patients who under-
went operation during this period were included in this
prospective nonrandomized study. They were divided into
two groups: A, angioscopy (ie, with intraoperative angio-
scopic assistance) and B, no angioscopy. 
All patients underwent a standardized preoperative
workup (clinical examination, pressure measurements with
calculation of ankle-brachial pressure index [ABPI] and
angiography). Demographic data, risk factors and clinical
status are listed in Table I. With the patient in the stand-
ing position, mapping of the saphenous vein was done
before surgery with color-flow duplex scanning (GE
Vingmed System 5, Horton, Norway), and the size of the
vein, number of branches, and defects or anomalies were
recorded.
Surgical procedure and intraoperative investiga-
tions and protocol. All patients received antibiotic pro-
Autogenous vein grafts in situ provide a superb con-
duit for distal bypasses. However, the longevity is, apart
from poor vein quality and technical errors during surgery,
threatened by postoperative arteriovenous fistulas or later
development of stenosis. Preoperative duplex scanning of
the vein has been shown to be valuable in the assessment
of postthrombotic stenosis or occlusion and varicosities of
the proposed graft, information that is important for the
preoperative decision whether the vein is useful as a bypass
graft.1,2 Furthermore, it has been shown to be an excellent
method to localize the tributaries that should be ligated
through multiple skin incisions during surgery.3
Angioscopy has not gained full recognition, but it has
been demonstrated that poor vein quality and unligated
tributaries could be identified by angioscopy.4-7 However,
whether angioscopic assistance improves the graft out-
come in patients with critical ischemia is debated. This
prospective study was designed to evaluate whether
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Objective: To find out whether intraoperative angioscopic assistance has any effect on graft outcome in patients with
critical leg ischemia.
Material and Methods: One hundred one patients requiring a below-knee bypass were assigned to undergo in situ saphe-
nous vein bypass with or without intraoperative angioscopic assistance; otherwise treated similarly including preoper-
ative duplex vein mapping, intraoperative graft flow measurements, and angiography. Data on operative details,
morbidity, hospital stay, and graft patency were collected prospectively and compared. All patients were followed up for
12 months.
Results: The group that underwent angioscopy (A) and the control group (B) were similar in all respects, except for the
number of patients enrolled in the groups (32 and 69, respectively). Angioscopy revealed incompletely destructed valves
in 34 patients (range, 0 to 5; mean 1), undiagnosed vein branches in 111 patients (mean 4.3), and partly occluding
thrombus in 5 patients. The number of postoperative arteriovenous fistulas with signs of failing graft and a need for
angiographic or surgical reintervention were significantly higher in group B (P < .0001). The 1-year primary patency
rate was significantly better in group A (P < .01), but the primary assisted and secondary patency rates did not differ
between the groups.
Conclusions: Angioscopic assistance has an impact on primary graft patency, minimizes the risk for graft failure and thus
reduces the need for reintervention by allowing identification of persistent saphenous vein branches, incomplete valve
destruction, and partly occluding graft thrombus without adding extra operative time. (J Vasc Surg 2002;35:759-65.)
phylaxis with cloxacillin (Ekvacillin; Astra, Södertälje,
Sweden) 2 g intravenously administered three times, start-
ing just before surgery and at 8-hour intervals. The prox-
imal and distal anastomotic areas of the arteries were
exposed, as were the corresponding segments of the
saphenous vein. Before the vein was clamped, heparin
5000 units was given intravenously, and the most proximal
cusps were cut under direct vision after division at the
saphenofemoral junction. The proximal anastomosis was
performed end-to-side at the common femoral bifurca-
tion. The vein was exposed to arterial pressure and divided
distally, and a valvulotome (Vascutech Expandable
LeMaitre, Badsachen, Germany) was introduced from the
distal end. Valvulotomy was performed by pulling the
device through the vein at least twice or until no “cut” was
felt in the instrument. Vein branches that were mapped
before operation were then visualized through multiple
skin incisions and ligated.
In group A a 7F introducer was inserted into a branch
close to the proximal end of the saphenous vein. A 1.9- or
2.3-mm angioscope (Baxter, Irvine, Calif) connected to a
camera and light source (Storz, Tuttlingen, Germany) was
introduced into the vein (group A, angioscopy). Ringer’s
lactate solution with heparin 1 U/mL was used for irriga-
tion and infused via an infusion pump controlled by a foot
pedal, and the graft was inspected in an antegrade direc-
tion. During angioscopy the distal end of the vein was left
open so that the irrigation fluid could go out distally, thus
preventing fluid overload. The quality of the graft, the
number of residual valves and branches, stenotic areas, or
other defects in the vein, fresh thrombi, and instrumental
damage to the vein were recorded, as were the time used
for the investigation and the volume of irrigation fluid
used. Found branches were ligated immediately after
angioscopy. The bypass was completed after angioscopy in
group A and after valvulotomy in group B by performing
the distal anastomosis end to side. 
After restoration of blood flow, a 3- or 5-mm flow
probe was placed over the graft close to the proximal anas-
tomosis, and a transit time flowmeter (CardioMed/Medi-
Stim, Grefsen, Norway) was used to assess patency and to
identify additional branches. This was done by digital
occlusion of the graft on different levels from the probe.
Continuous proximal flow in spite of vein compression
indicated an overlooked branch, which was identified and
ligated. 
Finally intraoperative angiography (Stenoscop, Loncin,
Belgium) was performed to assess patency, to control the
anastomosis and runoff, and to detect overlooked fistulas.
These were ligated, and other defects were corrected and
recorded. After completion of the reconstruction, the final
blood flow in the graft was measured and recorded, as was
the operating time and blood loss. The procedures were
performed by two staff surgeons or by a vascular fellow
assisted by the surgeon, all of whom were familiar with the
operation and had some angioscopic experience. 
Postoperative follow-up and protocol. Data from
the postoperative period included reoperations, wound
problems, hospital stay, and early graft occlusion.
Postoperative clinical examination was performed at 1
and 12 months. A postoperative graft surveillance pro-
gram was followed and performed at 1, 3, 6, 9, and 12
months and included ABPI measurements and color-
flow duplex scanning investigations (GE Vingmed
System 5) by use of a 10-MHz probe. Two trained vas-
cular laboratory technologists performed all duplex scan-
ning and ankle-pressure measurements. Angiographic
examination was performed if one of the following signs
for failing graft was present: recurrent symptoms of leg
ischemia, patent fistulas causing a decrease in the graft
flow > 50% distal to the fistulas, significant graft stenosis
where the peak systolic velocity ratio was > 3.0, or
decrease of the ABPI by > 0.2.
If a stenosis (>70%) or a patent fistula was observed at
angiographic investigation, a revision procedure was per-
formed, either as an immediate percutaneous transluminal
angioplasty (PTA) or a transluminal “coiling” of the fistula
or later as an open surgical procedure.9,10 In case of an
insignificant stenosis or a patent arteriovenous fistula
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Table I. Patients’ characteristics and indication for oper-
ation
A (n = 32) B (n = 69)
Age (y)
Median 74 74
Range (53-91) (47–88)
Sex (male) 20 (63%) 38 (55%)
Diabetes
Total 17 (53%) 34 (49%)
Insulin dependent 11 25
Smoking 16 (50%) 35 (51%)
Cerebrocardiovascular disease 18 (57%) 52 (75%)*
Nephrosclerosis / uremia 3 (9%) 9 (13%)
Any previous peripheral 
vascular surgery 4 (13%) 14 (20%)
Rest pain 30 (94%) 65 (94%)
Ischemic ulcer/gangrene 23 (71%) 50 (72%)
*P < .01.
Table II. Result of preoperative vascular workup
A B
Vein-mapping 26 (80%) 62 (90%)
Vein diameter ≤3 mm 17 (65%) 45 (73%)
Vein branches
Median 8 8
Range (4-16) (3-15)
ABPI 28 (88%) 56 (82%)
ABPI < 0.4 all patients 15 (54%) 34 (61%)
Diabetes 15/5 (33%) 25/9 (36%)
No diabetes 13/10 (77%) 31/25 (81%)
Angiography/runoff 32 69
1 artery 26 (81%) 52 (75%)
2 arteries 6 (19%) 15 (22%)
3 arteries 0 2 (3%)
(AVF) with an insignificant flow steal, no further inter-
vention was undertaken, but subsequent surveillance
duplex examinations were performed at reduced intervals.
Data analysis. The patients were followed up for 12
months and primary assisted patency rates were calculated
by Kaplan-Meier survival estimates, and the data were
compared with log-rank test. Nonparametric variables were
presented as median, and the significance of any difference
was calculated with the Mann-Whitney test. Categorical
parameters were compared by use of 2 analysis. P values
< .05 were considered significant.
RESULTS
In the study 101 patients were enrolled: 32 patients in
the angioscopy group A and 69 in the control (no
angioscopy) group B. The intention was to include 100
patients, 50 in each group. We used the angioscope in every
second patient; no other criteria for selection was used.
Problems with our angioscopic equipment made angioscopy
impossible for a period during the study. Because of
European community regulations we could not repair our
equipment or get new equipment, which meant that the
condition of this equipment decided in which group patients
were included, rather than the operating surgeon or random
selection. Therefore there are significantly fewer patients in
the angioscopy group.
One patient from each group did not complete the
surveillance program as scheduled. However, their grafts
were patent at 1 year. Demographic data depicted in Table
I were all similar in the two groups, with the exception of
cerebrocardiovascular disease, which was seen slightly
more often in group B.
Preoperative angiography showed only one distal
runoff artery in approximately 80% of the patients and no
difference between the groups (Table II). The percentage
of patients who underwent preoperative vein mapping did
not differ between the groups. The scanning time was 15
minutes per patient. The vein diameter varied but was <3
mm in some part in approximately 70%, and the number
of tributaries was similar in both groups. All veins were
considered suitable for use as a bypass graft. No operation
was prematurely finished as a result of a vein being con-
sidered useless at surgery. ABPI was < 0.4 in 54% and 61%
in the respective groups. If patients with diabetes were
excluded, ABPI was <0.4 in almost 80% (Table II).
The proximal anastomosis was in most cases per-
formed at the bifurcation of the common femoral artery,
although in a few cases it was performed at the proximal
part of the superficial femoral artery or the deep femoral
artery. The distal anastomoses were constructed below the
knee and approximately 60% to a crural or pedal artery
(Table E I, online only). The quality of the arteries and the
veins assessed by the two surgeons did not differ between
the two groups.
During angioscopy 172 saphenous vein branches (of
these 111 in premapped veins), 34 residual valves (17
patients), and 5 partially occluding thrombi were found.
In three cases the angioscope damaged the vein because of
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varicose or postthrombotic disease. Angioscopic data are
presented in Table III.
By flowmetry further branches were found in both
groups, although significantly more were found in group
B (P > .01). However, a few were found during intraop-
erative angiography; more were found in group B,
although the difference was not significant. Adding the
number of unligated branches found by flowmetry and
angiography resulted in a convincing difference (P < .005)
between the two groups (Table IV). The median number
of vein branches in patients who underwent premapping
found by all investigative modalities was 14 and 11 in
groups A and B, respectively (P < .05). Further residual
valve cusps found by flowmetry or angiography was none
in group A and four in B (Table IV). 
The operating time was similar, but the intraoperative
blood loss was less in group B (430 and 320 mL, respec-
tively; P < .05). There were no differences between the
groups regarding the number of reoperations, postopera-
tive local complications (hematoma, infections, wound
necrosis, edema), or postoperative hospital stay (Table E
II, online only).
Criteria for failing graft were present in two patients in
group A because of graft stenosis and in 18 and 10
patients in group B because of AVFs and stenosis, respec-
tively (Table V). The difference in the number of signifi-
cant AVF between the groups was statistically significant
(P < .0001), as was the difference in the total number of
primary failing graft, regardless of cause. 
The AVF in group B (18 grafts) that were judged as
hemodynamically significant were all scheduled for treat-
ment but one. Six grafts occluded—four while waiting for
investigation and one was not diagnosed until after graft
failure. The last patient was opposed to any further inves-
tigation because of absence of symptoms. However,
shortly thereafter the graft occluded, and symptoms of
critical ischemia recurred. In spite of thrombolysis none of
these grafts could be saved (Table V). Four of the 12
treated patients later had development of stenosis distal to
the occluded AVF.
The two primary graft stenoses in group A and six in
group B were successfully treated by PTA (Table V).
Three grafts in group B occluded before scheduled treat-
ment and could not be reopened. 
A second episode of failing graft, caused by stenosis,
was seen in six patients in group B, and five were success-
fully treated by PTA (Table V). The increase in ABPI in
patent grafts 1 year after operation was 0.6 in both groups
(Table E III, online only).
In three patients in group A and two in group B,
wound dehiscence caused by massive leg edema, local skin
necrosis, and infection over the distal anastomosis resulted
in graft occlusion. It was not possible to reopen those grafts.
The 1-year primary patency rate was 69% in group A,
which was significantly higher than the 42% in group B (P
< .01). The primary assisted patency rate was 72% and 70%
in groups A and B, respectively, with no statistically signif-
icant difference (Figs 1 and 2).
Seven grafts in the angioscopic group and 20 in group
B occluded during the surveillance period. Early deaths
(within 30 days) included three patients in each group,
and the 1-year mortality rate was 10% in both groups. All
but two (in group B) had patent grafts at the time of
death. The amputation rate was 16% and 7% in groups A
and B (P = .17), respectively, all of which had occluded
grafts.
DISCUSSION
Different preoperative, intraoperative, and postopera-
tive investigations, such as duplex vein mapping, intraop-
erative angiography, angioscopy, flow measurements, and
specially designed surveillance programs, have been advo-
cated to improve the surgical outcome of in situ distal
bypass grafting.10-13 The operative technique may thereby
be refined, minimizing the risk for technical errors and
also implying a possibility for an early correction, thus
improving the operative results. It may also give an indi-
cation of the outcome of the procedure.14-17
Preoperative mapping is not a standard procedure, but
Maini et al3 described its advantages in 1993. When trib-
utaries are localized before surgery, they can be ligated
through small skin incisions before other intraoperative
investigations are performed. Preoperative vein scanning
also reduces postoperative wound complications, because
several small skin incisions are used instead of a long inci-
sion to visualize the entire vein. Our experience of map-
ping agrees with that of Maini’s group: early ligation of
mapped branches, better angioscopic sight with less irriga-
tion fluid, and easier diagnosis of fistulas by flowmetry and
angiography. 
Angioscopy has so far not gained full recognition.
Some surgeons even find it unnecessary.18 Others still
consider it to be an excellent method for an intraoperative
evaluation of the vein bypass, thereby reducing the risk for
eventual graft failure.19-21 Our results support this state-
ment. 
Maini et al3 found that the length of hospital stay and
wound complications were significantly reduced. However,
in contrast to our study, they did not observe any impact
on the 12-month primary patency rates. 
Wilson et al6,22 and others23 have elucidated the rele-
vance of the quality of the vein for the success of bypass
grafting. On the basis of these studies, they also stated that
using an angioscope with care did not cause significant dis-
ease for the later graft function. This is supported by other
published series.3,6,18 In a couple of cases in group A, we
found changes in the vein wall indicating preexisting dis-
ease, such as fibrous strands or local fibrous stenosis, with
anticipated negative effects on future graft function if not
taken care of. This may explain why primary stenosis devel-
oped earlier in group B, where these preexisting defects
were less likely to be visualized during surgery. Our data
have not indicated any obvious risk for endothelial damage
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Fig 2. One-year primary assisted patency rate. There is no differ-
ence between groups A (solid line) and B (dashed line). Numbers
represent grafts available for follow-up at 3, 6, and 12 months.
Standard error < 10% at 12 months for both groups.
Fig 1. One-year primary patency rate. There is significant differ-
ence between group A (solid line) and group B (dashed line) (P <
.01). Numbers represent grafts available for follow-up at 3, 6, and
12 months. Standard error < 10% at 12 months for both groups.
Table III. Result of angioscopic investigation
Angioscopy (n = 32) Total Median/mean
Irrigation fluid 
mL 550
Range (200-1000)
Residual valve cusps (n = 17) 34 2
Branches
Total 172
Only premapped veins (n = 26) 111 4.3
Thrombi 5
Vein damage 3*
*One was caused by varicose vein (12 months patent), two were due to
fibrous changes (one occluded, one patient died at <1 year).
caused by the angioscope and later graft failure. However,
it is notable that the time elapsed from surgery to the
occurrence of the stenosis was longer in group A than in
group B. Interestingly, within the observation period
restenoses were seen only in group B approximately 300
days after operation, that is at the time when the problem
first arose in group A. A further indication that angioscopy
probably has little or no negative long-term effects on the
endothelium. In our study 10% of the grafts developed sig-
nificant stenosis. Others have reported up to 30% graft
stenosis within the first year.24-27 The cause of vein graft
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stenosis in the in situ graft is not quite understood; how-
ever, several authors believe that there are predisposing fac-
tors such as vein size, tributaries, valve cusps, structure, and
effect of the valvulotomy.25,28-30
In our two groups preoperative mapping did not indi-
cate significant differences in vein diameter, number of
tributaries, or abnormal structure. In group A the result of
valvulotomy could be inspected and, in cases of incom-
plete valve destruction, immediately corrected. Obviously
this was impossible in group B, and, if the number of
incompletely cut valves was the same in both groups, only
Table IV. Number of fistulas and residual valve cusps found with flowmetry or angiography
A B
all (n = 32) all (n = 69)
premapped (n = 26) premapped (n = 62)
Flowmetry
Fistulas
All 39 158
Only premapped 31 140*
Median premapped 1 2*
Valve cusps (residual) 0 3
Angiography
Fistulas
All 10 48
Only premapped 9 42
Valve cusps (residual) 0 1
Flowmetry and angiography
Fistulas
All 49 206
Only premapped 40 182†
Median premapped 1 2†
Statistical calculations are made only on patients who underwent premapping.
*P < .01.
†P < .005.
Table V. Result of postoperative surveillance by duplex Doppler scanning and clinical inspection and treatment of AVF
and stenosis by surgery, coiling, or PTA
A (n = 32) B (n = 69)
Postoperative surveillance Fistula/stenosis Grafts Successful treatment* Fistula/stenosis Grafts Successful treatment*
AVF at 1 month 0 0 — 45 28
Nonsignificant AVF/
spontaneous AVF occlusion — — 15 10
Failing graft—primary
Significant fistulas 0 0 30† 18
Treated AVF coil/surgery — — 19 12 12
Stenosis distal to AVF — — — 1 1
No treatment graft occlusion — — 11 6 0
Stenosis distal to AVF — — — 2 0
Significant stenoses 2 2 10 10
Days after surgery (range) 305-365 30-100
Treated stenosis PTA/surgery 2 2 2 7 7 6
No treatment graft occlusion — — — — 3 0
Failing graft—secondary
Stenosis 0 0 0 6 6 5
Days after surgery (range) 144-339
Graft fistulas are found only in group B, and significant stenoses are more frequently seen in group B, but without significance.
*Defined as a patent graft.
†P < .0001.
a small fraction of them were found by flowmetry or
angiography. Is an incompletely disrupted valve cusp after
all a focus for the formation of early stenosis as was found
in group B? This could mean that the pathogenesis for
strictures differs in the two groups. In light of our results
the role of the cusps cannot with certainty be discarded.
However, if residual valves are one of the causes, the effec-
tiveness of the valvulotome must be questioned. 
Flowmetry is not the method of choice to diagnose
problems with incompletely divided leaflets. Those found in
this study were a result of the exclusion of other causes for
an extremely low flow in an otherwise good bypass graft.
This suspicion was confirmed by angiography. Angiography
is, however, inferior to angioscopy for detection of incom-
plete disruption of valve cusps or other intimal defects6,31-
33 but is a good complement for visualization of the distal
anastomosis and the runoff situation. 
The most striking result in our study is the complete
absence of postoperative AVF in the angioscopy group. We
believe it is important to ligate hemodynamically signifi-
cant AFVs.34,35 In spite of careful preoperative duplex
scanning of the vein, we failed to visualize all branches. In
group A these overlooked AVF were found and ligated.
Probably, some insignificant branches were also ligated.
This is indicated by the fact that there were significantly
more branches in group A, even if the number of AVF
found after operation in group B were added. Furthermore
several AVF found during the postoperative surveillance
program were considered hemodynamically insignificant.
They all occluded spontaneously. Angioscopy may result in
overtreatment of AVF with no hemodynamic significance,
but we believe that this is justified by the fact that 18
(26%) patients in group B perhaps would not have needed
a reintervention, neither surgical nor radiologic. Besides,
reinterventions are both time consuming and costly.
Lundell and Nyborg34 reported 98 in situ bypasses, with
18% overlooked AVF that needed revision. Similar results
are reported by van Dijk et al.36 In a study with angio-
scopic assistance made by Rosenthal et al37 the number of
disregarded AVF was only 6%, a result that is in agreement
with ours. During operation there is a risk for spasm in the
branches temporarily abolishing their flow, making them
difficult to find with flow measurement or angiography. In
spite of papaverine injection into the graft, we did not
detect further AVF. 
Finally, it is known that some significant branches have
competent valves in the orifice, readily seen with the
angioscope in group A but impossible to diagnose and
thus never taken care of in group B. With increasing flow
and pressure in the graft, these valves eventually yielded,
and an AVF was created.
Fluid volume administered to patients during angios-
copy could be hazardous, especially when given to this
group of elderly patients with a high frequency of heart dis-
ease.18 We have reduced the flush volume by early ligation
of the graft branches before angioscopy and by doing most
of the investigation before the distal anastomosis was fin-
ished. Most of the irrigation fluid is thereby flushed through
the distal end of the graft. The final angioscopic control is
thereafter possible to do with a small amount of fluid. 
Angioscopy revealed a lot of valve remnants, which
would otherwise not have been found. We treated them
during surgery, because we believed that would optimize
flow. However, it is not known how many of these were of
clinical significance. Whether the valvulotome used had
any negative effect on the number of valve remnants is not
possible to evaluate. Compared with other devices we have
used, this valvulotome has been easy to handle, and no
complications caused by the instrument, such as perfora-
tion or rupture, were recorded. 
In conclusion we have confirmed the advantage of
using angioscopy for in situ vein graft preparation.
Angioscopy improved the primary graft patency rate by
early detection of AVF, uncut valve cusps, and other
defects and accordingly reduced the need for later reinter-
vention. From our experience we consider angioscopy a
good investigative modality, but more as a complement to
flow measurement and angiography than a replacement. 
With a more modern technique with angioscopic side
branch occlusion during surgery, the number of skin inci-
sions may be significantly reduced, with even fewer skin
problems and also reduced operating times, as described
by Rosenthal.4 This study has also indicated that preoper-
ative visualization and quality assessment of the vein with
duplex Doppler scanning is invaluable in helping to make
the angioscopic investigation faster and easier and thus has
an unambiguous effect on the results of surgery. 
Whether the valvulotome technique used in this study
had any implication is difficult to evaluate. The finding of
incompletely incised valves in both groups is open for
speculation, and probably the perfect valvulotome is yet to
be found.
We thank Christel Jungbeck and Karin Peterson, our
two very competent vascular laboratory technologists, for
their alertness and zeal.
REFERENCES
1. Panetta TF, Marin ML, Veith FJ, Goldsmith J, Gordon RE, Jones AM,
et al. Unsuspected preexisting saphenous vein disease: an unrecognised
cause of vein by pass failure. J Vasc Surg 1992;15:102-12
2. Kupinski AM, Evans SM, Khan AM, et al. Ultrasonic characterisation
of the saphenous vein. Cardiovasc Surg 1993;1:513-7.
3. Maini BS, Andrews L, Salimi T, Hendershott TH, O’Mara P. A mod-
ified, angioscopically assisted technique for in situ saphenous vein
bypass: impact on patency, complications, and length of stay. J Vasc
Surg 1993;17:1041-7.
4. Rosenthal D. Angioscopy in vascular surgery. Cardiovasc Surg 1997;
5:245-55.
5. Wilson YG, Davies AH, Currie IC, McGrath C, Morgan M, Baird RN,
et al. Angioscopically-assisted in situ saphenous vein bypass for infrain-
guinal revascularisation. Eur J Vasc Endovasc Surg 1996;12:223-9.
6. Wilson YG, Davies AH, Currie IC, McGrath C, Morgan M, Sheffield
E, et al. Angioscopy for quality control of saphenous vein during
bypass grafting. Eur J Vasc Endovasc Surg 1996;11:12-8.
7. Stonebridge PA, Murie JA. Vascular endoscopy: useful tool or inter-
esting toy. Br J Surg 1994;81:633-4.
8. Fontaine R, Kim M, Kieny-R. Die Chirurgische Behandlung der
peripheren Durch-blutungsstörungen. Helvetia Chirurgica Acta
1954;5/6:199-533.
JOURNAL OF VASCULAR SURGERY
764 Thorne et al April 2002
9. Caps MT, Cantwell Gab K, Bergelin RO, Strandness DE Jr. Vein graft
lesions: time of onset and rate of progression. J Vasc Surg
1995;22:466-74.
10. Idu MM, Buth J, Hop WC, Cuypers P, van de Pavoordt ED, Tordoir
JM. Vein graft surveillance: is graft revision without angiography jus-
tified and what criteria should be used? J Vasc Surg 1998;27:399-411.
11. Lundell A, Lindblad B, Bergqvist D, Hansen F. Femoropopliteal-
crural graft patency is improved by an intensive surveillance program:
a prospective randomized study. J Vasc Surg 1995;21:26-33.
12. Moody P, de Cossart LM, Douglas HM, Harris PL. Asymptomatic stric-
tures in femoro-popliteal vein grafts. Eur J Vasc Surg 1989;3:389-92.
13. Idu MM. Surveillance of infrainguinal autologous vein bypasses [the-
sis/dissertation]. Rotterdam; 1998.
14. Stirnemann P, Ris HB, Do D, Hammerli R. Intraoperative flow mea-
surement of distal runoff: a valid predictor of outcome of infrainguinal
bypass surgery. Eur J Surg 1994;160:431-6.
15. Lundell A, Bergqvist D. Prediction of early graft occlusion in
femoropopliteal and femorodistal reconstruction by measurement of
volume flow with a transit time flowmeter and calculation of periph-
eral resistance. Eur J Vasc Surg 1993;7:704-8.
16. Ihlberg L, Luther M, Albäck A, Kantonen I, Lepäntalo M. Does a
completely accomplished duplex-based surveillance prevent vein-graft
failure? Eur J Vasc Endovasc Surg 1999;18:395-400.
17. Karacagil S, Almgren B, Bergström R, Bowald S, Eriksson I.
Postoperative predictive value of a new method of intraoperative
angiographic assessment of run-off in femoropopliteal bypass grafting.
J Vasc Surg 1989;10:400-7.
18. Clair DG, Golden MA, Mannick JA, Whittemore AD, Donaldson
MC. Randomized prospective study of angioscopically assisted in situ
saphenous vein grafting. J Vasc Surg 1994;19:992-9.
19. Miller A, Lipson WP, Isaacsohn JL, Schoen FJ, Lees RS.
Intraoperative angioscopy: principles of irrigation and description of a
new dedicated irrigation pump. Am Heart J 1989;118:391-9.
20. Miller A, Stonebridge PA, Tsoukas AI, Kwolek CJ, Brophy CM,
Gibbons GW, et al. Angioscopically directed valvulotome: a new
valvulotome and technique. J Vasc Surg 1991;13:813-21.
21. Miller A, Stonebridge PA, Jepsen SJ, Tsoukas A, Gibbons GW,
Pomposelli FB Jr, et al. Continued experience with intraoperative
angioscopy for monitoring infrainguinal bypass grafting. Surgery
1991;109:286-93.
22. Wilson YG. Vein quality in infrainguinal revascularisation: assessment
by angioscopy and histology. Ann R Coll Surg Engl 1998;80:3-15.
23. Marin ML, Veith FJ, Panetta TF, Gordon RE, Wengerter KR, Suggs
WD, et al. Saphenous vein biopsy: a predictor of vein graft failure. J
Vasc Surg 1993;18:407-14.
24. Wilson YG, Davies AH, Currie IC, Morgan M, McGrath C, Baird
RN, et al. Vein graft stenosis: incidence and intervention. Eur J Vasc
Endovasc Surg 1996;11:164-9.
JOURNAL OF VASCULAR SURGERY
Volume 35, Number 4 Thorne et al 765
25. Davies AH, Magee TR, Sheffield E, Baird RN, Horrocks M. The aeti-
ology of vein graft stenoses. Eur J Vasc Surg 1994;8:389-94.
26. Szilagyi DE, Elliott JP, Hageman JH, Smith RF, Dall’olmo CA.
Biologic fate of autogenous vein implants as arterial substitutes: clini-
cal, angiographic and histopathologic observations in femoro-
popliteal operations for atherosclerosis. Ann Surg 1973;178:232-46.
27. Wolfe JHN, Taylor PR, Cheshire NJ. The maintenance of arterial
reconstruction. In: Greenhalgeh RM,Hollier LH, editors. Graft sur-
veillance—a biased overview. London: Saunders; 1991. p. 119-28.
28. Sayers RD, Watt PA, Muller S, Bell PR, Thurston H. Structural and
functional smooth muscle injury after surgical preparation of reversed
and non-reversed (in situ) saphenous vein bypass grafts. Br J Surg
1991;78:1256-8.
29. Milroy CM, Scott DJ, Beard JD, Horrocks M, Bradfield JW.
Histological appearances of the long saphenous vein. J Pathol
1989;159:311-6.
30. Moody AP, Edwards PR, Harris PL. The aetiology of vein graft stric-
tures: a prospective marker study. Eur J Vasc Surg 1992;6:509-11.
31. Gilbertson JJ, Walsh DB, Zwolak RM, Waters MA, Musson A,
Magnant JG, et al. A blinded comparison of angiography, angioscopy,
and duplex scanning in the intraoperative evaluation of in situ saphe-
nous vein bypass grafts. J Vasc Surg 1992;15:121-7.
32. Woelfe KD, Kuegelman U, Bruijnen H, Storm G, Loeprecht H.
Intraoperative imaging techniques in infrainguinal arterial bypass
grafting: completion angiography versus vascular endoscopy. Eur J
Vasc Surg 1994;8:556-61.
33. Neville RF Jr, Yasuhara H, Watanabe BI, Canady J, Duran W, Hobson
RW II. Endovascular management of arterial intimal defects: an
experimental comparison by arteriography, angioscopy, and intravas-
cular ultrasonography. J Vasc Surg 1991;13:496-502.
34. Lundell A, Nyborg K. Do residual arteriovenous fistulae after in situ
saphenous vein bypass grafting influence patency? J Vasc Surg
1999;30:99-105.
35. Gwynn BR, Shearman CP, Simms MH. The influence of patent
branches on in situ vein graft haemodynamics. Eur J Vasc Surg
1987;1:169-72.
36. van Dijk LC, van Urk H, Lameris JS, Wittens CH. Residual arteri-
ovenous fistulae after “closed” in situ bypass grafting: an overrated
problem. Eur J Vasc Endovasc Surg 1997;13:439-4.
37. Rosenthal D, Dickson C, Rodriguez FJ, Blackshear WM Jr, Clark
MD, Lamis PA, et al. Infrainguinal endovascular in situ saphenous
vein bypass: ongoing results. J Vasc Surg 1994;20:389-94.
Submitted Feb 15, 2001; accepted July 17, 2001.
Additional material for this article may be found online
at www.mosby.com/jvs.
